Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Replacing Saquinavir HGC with SGC in HIV-1 Infection
NCT00002374Phase 3Completed
- Sponsor
- Roche
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saquinavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Status: completed.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00002374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002374.